MedPath

Effect of topical nitroglycerin on improvement of peripheral perfusion in critically ill patients with vasopressors

Not Applicable
Conditions
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Registration Number
KCT0008559
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Adult patients (19 years or older) in surgical intensive care unit who are treated with vasopressors.

Exclusion Criteria

Patients under 18 years
Patients who cannot provide voluntary consent due to impaired consciousness
Pregnant or breastfeeding patients
Patients with vascular diseases
Patients with thrombosis or embolism in the relevant ulnar artery on ultrasound examination
Patients with a history of hypersensitivity or adverse reactions to nitroglycerin
Patients who have taken other nitrates within the past 24 hours
Patients taking phosphodiesterase-5 inhibitors (such as sildenafil, vardenafil, tadalafil, etc.)
Patients with headaches or dizziness
Patients with glaucoma or increased intracranial pressure
Patients with methemoglobinemia
Patients with skin lesions at the application site

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Distal peripheral perfusion index
Secondary Outcome Measures
NameTimeMethod
Change (%)of diameter and area of radial artery and distal perfusion index, AUC of perfusion index, ischemic injury of distal finger, length of icu stay, and in-hospital mortality
© Copyright 2025. All Rights Reserved by MedPath